Sort
10,766 grants matching “checkpoint inhibitor”
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer
$248,999Christopher J. Halbrook · University Of California-Irvine · R00 · FY2020 · CA
An individualized network medicine infrastructure for precision cardio-oncology
$248,999Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R00 · FY2020 · HL
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
$248,998Defne Bayik Watson · University Of Miami School Of Medicine · R00 · FY2025 · CA
Molecular Programming of CD8+ T Cell Accumulation and Activity in Tumors
$248,997John Justin Milner · Univ Of North Carolina Chapel Hill · R00 · FY2020 · CA
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
$248,997Defne Bayik Watson · University Of Miami School Of Medicine · R00 · FY2023 · CA
Molecular Programming of CD8+ T Cell Accumulation and Activity in Tumors
$248,997John Justin Milner · Univ Of North Carolina Chapel Hill · R00 · FY2022 · CA
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
$248,995Defne Bayik Watson · University Of Miami School Of Medicine · R00 · FY2024 · CA
Dissecting the Myeloid-Th17 axis in the pathogenesis of Colitis-associated Colorectal Cancer
$248,936Awalpreet Singh Chadha · University Of Alabama At Birmingham · R00 · FY2025 · CA
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
$248,813Joseph Markowitz · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2022 · CA
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
$248,813Joseph Markowitz · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2021 · CA
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7
$248,807Harvard University (Medical School) · R01 · FY2001 · CA
Radiation-induced targeted extracellular vesicles -based gene delivery for glioma therapy
$248,600Bakhos A. Tannous · Massachusetts General Hospital · R21 · FY2020 · NS
Checkpoint Abrogation and MEK 1/2 Inhibition in Myeloma
$248,557Steven Grant · Virginia Commonwealth University · R01 · FY2010 · CA
Genomics Core
$248,500Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2025 · CA
PI3K opposes p27 and G1 arrest by TGF-B in human cancer
$248,460University Of Miami School Of Medicine · R01 · FY2005 · CA
PI3K opposes p27 and G1 arrest by TGF-B in human cancer
$248,460University Of Miami School Of Medicine · R01 · FY2004 · CA
INDUCTION OF P21 AND P27 IN LIVER AFTER CCL4 INJURY
$248,444University Of Illinois At Chicago · R01 · FY2001 · DK
Project 1: Personalized Adjuvant Immunotherapy for High-risk Colorectal Cancer.
$248,431Michael J Overman · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis
$248,319David R Spriggs · Sloan-Kettering Inst Can Research · U01 · FY2011 · CA
Project 2: Microenvironment Modification and Anti-PD1 Immunotherapy of Lymphoma
$248,267George J Weiner · University Of Iowa · P50 · FY2019 · CA
Quantitative PET Imaging for Oncologic Immune Response Prediction
$248,261Benjamin M Larimer · University Of Alabama At Birmingham · R00 · FY2021 · CA
Functional study of C53 protein as a novel regulator of checkpoint kinases
$248,259Honglin Li · Augusta University · R01 · FY2011 · GM
Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer
$248,243Judy Lieberman · Boston Children'S Hospital · R21 · FY2023 · CA
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
$247,971Jinsong Liu · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
$247,971Jinsong Liu · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA